- Home
- IMCC vs CODX Comparison
IMCC vs CODX Comparison
Compare IMCC & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCC
- CODX
- Stock Information
- Founded
- IMCC 1980
- CODX 2013
- Country
- IMCC Israel
- CODX United States
- Employees
- IMCC N/A
- CODX N/A
- Industry
- IMCC Medicinal Chemicals and Botanical Products
- CODX Medical/Dental Instruments
- Sector
- IMCC Health Care
- CODX Health Care
- Exchange
- IMCC Nasdaq
- CODX Nasdaq
- Market Cap
- IMCC 12.2M
- CODX 9.8M
- IPO Year
- IMCC N/A
- CODX 2017
- Fundamental
- Price
- IMCC $1.87
- CODX $0.31
- Analyst Decision
- IMCC
- CODX Buy
- Analyst Count
- IMCC 0
- CODX 2
- Target Price
- IMCC N/A
- CODX $5.50
- AVG Volume (30 Days)
- IMCC 74.1K
- CODX 5.2M
- Earning Date
- IMCC 08-12-2025
- CODX 11-06-2025
- Dividend Yield
- IMCC N/A
- CODX N/A
- EPS Growth
- IMCC N/A
- CODX N/A
- EPS
- IMCC N/A
- CODX N/A
- Revenue
- IMCC $38,430,631.00
- CODX $1,003,653.00
- Revenue This Year
- IMCC $47.12
- CODX N/A
- Revenue Next Year
- IMCC $12.83
- CODX $31.58
- P/E Ratio
- IMCC N/A
- CODX N/A
- Revenue Growth
- IMCC 5.08
- CODX N/A
- 52 Week Low
- IMCC $1.29
- CODX $0.23
- 52 Week High
- IMCC $7.12
- CODX $1.40
- Technical
- Relative Strength Index (RSI)
- IMCC 32.26
- CODX 54.91
- Support Level
- IMCC $1.48
- CODX $0.30
- Resistance Level
- IMCC $2.48
- CODX $0.35
- Average True Range (ATR)
- IMCC 0.26
- CODX 0.03
- MACD
- IMCC -0.04
- CODX -0.00
- Stochastic Oscillator
- IMCC 34.45
- CODX 52.57
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.